Go Pro

Lexeo Therapeutics (LXEO) Institutional Ownership

Lexeo Therapeutics logo
$4.86 -0.13 (-2.61%)
As of 08/28/2026 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for Lexeo Therapeutics (NASDAQ:LXEO)

Current
Institutional Ownership
Percentage
60.67%
Number of
Institutional Buyers
(last 12 months)
78
Total
Institutional Inflows
(last 12 months)
$428.75M
Number of
Institutional Sellers
(last 12 months)
20
Total
Institutional Outflows
(last 12 months)
$65.75M
Get LXEO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lexeo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

LXEO Institutional Buying and Selling by Quarter

Lexeo Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/23/2026 Frazier Life Sciences Management L.P.4,824,725$22.46M0.5%+9.0%5.880%
8/20/2026 Montanova Capital LLC6,384,200$29.72M0.5%+410.7%7.781%
8/19/2026 Wellington Management Group LLP202,383$942K0.0%+17.2%0.247%
8/19/2026 Nantahala Capital Management LLC1,300,000$6.05M0.0%N/A1.584%
8/17/2026 Avoro Capital Advisors LLC1,489,189$6.93M0.0%N/A1.815%
8/17/2026 Bank of America Corp DE490,331$2.28M0.0%N/A0.598%
8/15/2026 Jupiter Topco LLC3,954,691$18.41M0.0%N/A5.036%
8/14/2026 ADAR1 Capital Management LLC1,565,950$7.29M0.3%N/A1.994%
8/14/2026 Canada Pension Plan Investment Board18,500$86K0.0%N/A0.024%
8/14/2026 Legal & General Group Plc6,882$32K0.0%N/A0.009%
8/14/2026 The Manufacturers Life Insurance Company 19,805$92K0.0%N/A0.025%
8/14/2026 Spruce Street Capital LP928,593$4.32M0.0%N/A1.183%
8/7/2026 BlackRock Inc.5,739,455$26.72M0.0%N/A7.310%
8/7/2026 Deutsche Bank AG82,293$383K0.0%N/A0.105%
8/7/2026 Mitsubishi UFJ Asset Management Co. Ltd.49,988$233K0.0%N/A0.064%
8/6/2026 Bank of New York Mellon Corp183,883$856K0.0%N/A0.234%
8/3/2026 Walleye Capital LLC73,868$344K0.0%N/A0.094%
7/9/2026 Hennion & Walsh Asset Management Inc.265,697$1.24M0.0%N/A0.338%
5/19/2026 Bank of America Corp DE491,532$2.82M0.0%+206.7%0.626%
5/19/2026Janus Henderson Group PLC4,976,429$28.51M0.0%-9.7%6.338%
5/18/2026 ADAR1 Capital Management LLC1,467,350$8.42M0.5%+5.3%1.869%
5/16/2026 Orbimed Advisors LLC3,602,450$20.68M0.4%+69.5%4.588%
5/15/2026 Octagon Capital Advisors LP1,100,000$6.31M0.7%-36.2%1.401%
5/15/2026 Affinity Asset Advisors LLC5,050,211$28.99M1.5%+57.8%6.432%
5/15/2026 Spruce Street Capital LP928,593$5.33M1.3%+430.6%1.183%
5/7/2026 Dimensional Fund Advisors LP1,103,584$6.33M0.0%+27.9%1.405%
5/5/2026 Bank of New York Mellon Corp158,899$912K0.0%-4.7%0.202%
5/4/2026 Bleakley Financial Group LLC47,964$275K0.0%N/A0.061%
4/27/2026 Y Intercept Hong Kong Ltd142,571$818K0.0%-38.3%0.192%
3/16/2026 Avoro Capital Advisors LLC3,300,000$32.77M0.3%N/A4.521%
3/3/2026 Caitong International Asset Management Co. Ltd3,714$37K0.0%N/A0.005%
2/19/2026 Invesco Ltd.463,029$4.60M0.0%N/A0.634%
2/18/2026 ADAR1 Capital Management LLC1,393,161$13.83M1.0%-9.1%1.909%
2/18/2026 XTX Topco Ltd11,144$111K0.0%-58.3%0.015%
2/18/2026 Ikarian Capital LLC513,011$5.09M0.4%-9.6%0.703%
2/18/2026 Vestal Point Capital LP4,475,000$44.44M1.5%+37.7%6.131%
2/18/2026 Virtus Investment Advisers LLC27,230$270K0.1%N/A0.037%
2/18/2026 Wellington Management Group LLP83,230$826K0.0%N/A0.114%
2/18/2026 Susquehanna Portfolio Strategies LLC26,205$260K0.0%+14.4%0.036%
2/18/2026 Suvretta Capital Management LLC1,250,000$12.41M0.3%N/A1.713%
These 3 Stocks Could Soar as Sam Altman Announces New Venture After OpenAI (Ad)

Elon Musk calls it the most disruptive force in history. Sam Altman is reportedly preparing a new venture after OpenAI, one some say could be 500 times bigger than ChatGPT. Test staff are said to be bound by law to keep details secret, and three lesser-known stocks may be tied to this next chapter in AI.tc pixel

Click here to see the stocks linked to Altman's next big move
2/18/2026 Orbimed Advisors LLC2,125,000$21.10M0.4%N/A2.911%
2/18/2026 Millennium Management LLC908,024$9.02M0.0%-60.8%1.244%
2/18/2026Janus Henderson Group PLC5,509,635$54.67M0.0%-9.8%7.549%
2/18/2026 Balyasny Asset Management L.P.1,635,026$16.24M0.0%-58.2%2.240%
2/18/2026 Bridgeway Capital Management LLC13,400$133K0.0%-72.3%0.018%
2/18/2026 Boothbay Fund Management LLC136,377$1.35M0.0%-24.5%0.187%
2/18/2026 683 Capital Management LLC1,120,000$11.12M0.5%+21.4%1.534%
2/17/2026 ADAR1 Capital Management LLC1,393,161$13.83M1.0%-9.1%1.909%
2/17/2026 Burkehill Global Management LP125,000$1.24M0.1%N/A0.171%
2/17/2026 AQR Capital Management LLC337,386$3.35M0.0%-3.0%0.462%
2/17/2026 RA Capital Management L.P.5,000,000$49.65M0.5%N/A6.850%
2/17/2026 Paradigm Biocapital Advisors LP4,763,198$47.30M1.2%N/A6.526%
2/17/2026 Price T Rowe Associates Inc. MD33,872$337K0.0%+183.1%0.046%
2/17/2026 California State Teachers Retirement System3,884$39K0.0%+123.7%0.005%
2/17/2026 Russell Investments Group Ltd.5,872$58K0.0%+160.2%0.008%
2/17/2026 Atom Investors LP68,491$680K0.1%N/A0.094%
2/17/2026 Avoro Capital Advisors LLC3,300,000$32.77M0.3%N/A4.521%
2/17/2026 Graham Capital Management L.P.32,898$327K0.0%N/A0.045%
2/17/2026 Persistent Asset Partners Ltd16,025$159K0.1%N/A0.022%
2/16/2026 OMERS ADMINISTRATION Corp20,900$208K0.0%N/A0.029%
2/16/2026 Squarepoint Ops LLC92,608$920K0.0%N/A0.127%
2/16/2026 Spruce Street Capital LP175,000$1.74M0.6%N/A0.240%
2/16/2026 Verition Fund Management LLC428,458$4.26M0.0%+3.3%0.587%
2/16/2026 Barclays PLC188,754$1.87M0.0%+69.2%0.259%
2/13/2026 Nantahala Capital Management LLC1,000,000$9.93M0.3%N/A1.370%
2/13/2026 The Manufacturers Life Insurance Company 19,147$190K0.0%N/A0.026%
2/13/2026 Affinity Asset Advisors LLC3,200,000$31.78M1.8%-17.3%4.384%
2/13/2026 Rafferty Asset Management LLC102,159$1.01M0.0%N/A0.140%
2/13/2026 Siren L.L.C.720,622$7.16M0.2%+19.4%0.987%
2/13/2026 Charles Schwab Investment Management Inc.192,210$1.91M0.0%+81.7%0.263%
2/13/2026 Police & Firemen s Retirement System of New Jersey16,373$163K0.0%+171.1%0.022%
2/13/2026 State Street Corp3,187,722$31.65M0.0%+485.1%4.367%
2/13/2026 Ieq Capital LLC24,692$245K0.0%-26.5%0.034%
2/13/2026 Wells Fargo & Company MN70,736$702K0.0%+267.2%0.097%
2/12/2026 Jane Street Group LLC140,096$1.39M0.0%+8.2%0.192%
2/12/2026 MetLife Investment Management LLC35,721$355K0.0%N/A0.049%
2/12/2026 Renaissance Technologies LLC217,772$2.16M0.0%+45.9%0.298%
2/12/2026 Dimensional Fund Advisors LP862,892$8.57M0.0%-5.4%1.182%
2/12/2026 New York State Common Retirement Fund19,887$197K0.0%+375.0%0.027%
2/12/2026 Nuveen LLC211,529$2.10M0.0%+539.0%0.290%
2/11/2026 Deutsche Bank AG57,166$568K0.0%+135.0%0.078%
2/11/2026 WINTON GROUP Ltd26,900$267K0.0%N/A0.037%
2/10/2026 Goldman Sachs Group Inc.781,855$7.76M0.0%+449.0%1.071%
2/10/2026 Intech Investment Management LLC14,188$141K0.0%+19.5%0.019%
2/9/2026 Geode Capital Management LLC1,445,887$14.36M0.0%+100.3%1.981%
2/6/2026 ProShare Advisors LLC14,752$146K0.0%N/A0.020%
2/5/2026 Allworth Financial LP3,386$34K0.0%+1,002.9%0.005%
2/3/2026 Mitsubishi UFJ Asset Management Co. Ltd.26,209$252K0.0%N/A0.036%
1/29/2026 UBS Group AG281,083$2.79M0.0%+12.5%0.385%
1/29/2026 China Universal Asset Management Co. Ltd.11,893$118K0.0%+25.6%0.016%
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company (Ad)

We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel

👉 Unlock the ticker now and get it completely free.
1/26/2026 Mirae Asset Global Investments Co. Ltd.3,547$35K0.0%+69.9%0.005%
1/9/2026 SG Americas Securities LLC18,640$185K0.0%N/A0.026%
11/17/2025 Vestal Point Capital LP3,250,000$21.58M1.0%+0.7%4.453%
11/17/2025 Scientech Research LLC13,502$90K0.0%N/A0.018%
11/17/2025 Millennium Management LLC2,313,642$15.36M0.0%-18.4%3.170%
11/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.11,453$76K0.0%-15.0%0.016%
11/17/2025 Brevan Howard Capital Management LP18,400$122K0.0%N/A0.025%
11/17/2025 Citadel Advisors LLC3,719,043$24.69M0.0%+3.1%5.095%
11/17/2025 Bank of America Corp DE28,279$188K0.0%+6.1%0.039%
11/17/2025 Boothbay Fund Management LLC180,744$1.20M0.0%+10.8%0.248%


LXEO Institutional Ownership - Frequently Asked Questions

During the previous two years, 119 institutional investors and hedge funds held shares of Lexeo Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($49.65M), Paradigm Biocapital Advisors LP ($47.30M), Vestal Point Capital LP ($44.44M), State Street Corp ($31.65M), Montanova Capital LLC ($29.72M), Affinity Asset Advisors LLC ($28.99M), and Janus Henderson Group PLC ($28.51M).Learn more on Lexeo Therapeutics' institutional investors.

60.67% of Lexeo Therapeutics' stock is owned by institutional investors. Learn more on LXEO's institutional investor holdings.

Of the 107 institutional investors that purchased Lexeo Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Avoro Capital Advisors LLC ($8.09M), BlackRock Inc. ($5.74M), Affinity Asset Advisors LLC ($5.44M), Montanova Capital LLC ($5.13M), Frazier Life Sciences Management L.P. ($5.12M), RA Capital Management L.P. ($5M), and Paradigm Biocapital Advisors LP ($4.76M).

Institutional investors have bought a total of 57,699,514 shares in the last 24 months. This purchase volume represents approximately $428.75M in transactions.

Of the 20 institutional investors that sold Lexeo Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Balyasny Asset Management L.P. ($2.37M), Millennium Management LLC ($1.93M), Janus Henderson Group PLC ($1.13M), Affinity Asset Advisors LLC ($670.53K), Octagon Capital Advisors LP ($625K), ADAR1 Capital Management LLC ($277.58K), and Y Intercept Hong Kong Ltd ($88.59K).

Institutional investors have sold a total of 7,372,725 shares in the last 24 months. This volume of shares sold represents approximately $65.75M in transactions.



Institutional ownership data for NASDAQ:LXEO is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/23/2026. New 13F filings are added each quarter as they're published.
From Our Partners